Authors
Susie Sanchez is an anal cancer thriver, advocate for HPV awareness, and passionate about helping others speak openly about cancer risks.
HER2-positive metastatic breast cancer patient.
MSN, RN, PMGT-BC.
Herigodt serves as the director of Partnerships and Engagement, a Cancer Support specialist, and director of Programs and Outreach at Imerman Angels.
Baker, a survivor and patient advocate based in the United Kingdom, received a diagnosis of essential thrombocythemia (ET) in 1991, followed by polycythemia vera (PV) in 2004.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Revtorpyk for Advanced HR-Positive, HER2-Negative Breast Cancer
2
GLP-1s: Weight Loss and Survival in Breast Cancer Recovery
3
FDA Grants Traditional Approval to Retevmo for RET Fusion-Positive Solid Tumors
4
Why "You'll Be Fine" Isn't Always Comforting After Cancer
5
